Track topics on Twitter Track topics that are important to you
Synbio startup Oxford Genetics has licensed CRISPR from Emmanuelle Charpentier’s company, ERS Genomics, to boost its platform. Synthetic biology has so far remained on the fringe of biotech, but one company, Oxford Genetics, is demonstrating its use in therapeutics. To ...
This awesome article Oxford Synbio Startup with Eyes on Therapeutics gets hold of CRISPR appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)
Original Article: Oxford Synbio Startup with Eyes on Therapeutics gets hold of CRISPRNEXT ARTICLE
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...